Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$19,128,162
+$3,059,784 QoQ
Shares Held
76,014
+2.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#628
of 4,153 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASTERINVEST Kapitalanlage GmbH holds $70,825,852 across 8 Drug Manufacturers - General names. ABBV ranks #2 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,755 | $29,691,892 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
76,014 | $19,128,162 | |
| 3 | JNJ |
Johnson & Johnson
|
30,423 | $7,726,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,103 | $4,896,235 | |
| 5 | AMGN |
Amgen Inc
|
11,907 | $4,311,762 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
25,094 | $3,170,375 | |
| 7 | PFE |
Pfizer Inc
|
56,941 | $1,371,139 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,194 | $529,758 |
All Filings in ABBV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,128,162 | 76,014 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $16,068,378 | 73,881 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $18,863,220 | 82,556 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $19,134,002 | 82,638 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $12,368,417 | 66,633 | Shares | Sole | 2025-08-26 | |
| No filing history on record for this holder in this stock. | ||||||